Ofatumumab is now listed in the interaction checker as a cancer drug and interactions can be found for all the comedications.
Ofatumumab (Arzerra®) is a monoclonal antibody and is indicated for the treatment of chronic lymphocytic B-cell leukemia.
SPONSORS
